| RHEUMATO-DERMATOLOGY SYMPOSIUM |
|
| Year : 2019 | Volume
: 3
| Issue : 1 | Page : 47-56 |
|
|
Disease-modifying antirheumatic drugs – Old and new: A brief overview
Vidya Divakar Baliga, Raghuveer S Prabhu
Department of General Medicine, Amrita Institute of Medical Sciences, Kochi, Kerala, India
Correspondence Address:
Raghuveer S Prabhu
Department of Medical Oncology and Hematology, Amrita Institute of Medical Sciences, Ponekkara, Kochi - 682 041, Kerala
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/CDR.CDR_50_18
|
|
|
Rheumatological disorders comprise a vast subset of conditions with differing manifestations but overlap in pathogenesis. Disease-modifying antirheumatic drugs (DMARDs) are a diverse group of medications which aim at the various pathogenic factors leading to these disorders. DMARDs are of three broad subtypes: the conventional synthetic DMARDs, the biologicals, and Janus kinase inhibitors. Here, we give a brief overview of the various DMARDs with an emphasis on their practical use.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
